Trial NCT02621021

View at ClinicalTrials.gov 
Org. Study IDs: 160027
Secondary IDs: 16-C-0027

Last trial update was posted on 2024-03-15

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine Pembrolizumab

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

The team is revising the protocol design and has chosen to put the study on hold until those changes are approved.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID